The incidence of heart disease ranges from 0.7% in the 18–44 age group and up to 13.3% in individuals 75 years or older.1 In developed countries, the prevalence of valvular heart disease is estimated at 2.5%.1
A more recent review of the current evidence for the global burden of rheumatic fever (RF) and RHD estimates that 15.6–19.6 million people have rheumatic heart disease (RHD) (2.4 million children aged 5–14 years).2 With the decline in RHD and the ageing population in the developed world, there has been a change in the disease patterns of valve lesions over the last fe decades. Western populations are experiencing greater numbers of degenerative valve disease.
In the developing world, however, RHD remains an important cause of valve pathology.
Author Biography A Mallier Peter, University of the WitwatersrandDepartment of Anaesthesia, Klerksdorp/Tshepong Hospital, Faculty of Health Sciences, University of the Witwatersrand, South Africa
Issue SectionFCA Refresher Course
LicenseBy submitting manuscripts to SAJAA, authors of original articles are assigning copyright to the SA Society of Anaesthesiologists. Authors may use their own work after publication without written permission, provided they acknowledge the original source. Individuals and academic institutions may freely copy and distribute articles published in SAJAA for educational and research purposes without obtaining permission.
The work is licensed under a Creative Commons Attribution-Non-Commercial Works 4.0 South Africa License. The SAJAA does not hold itself responsible for statements made by the authors.
留言 (0)